CONMED Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.74 | $0.74 | $0.74 |
Q2 2024 | 2 | $0.91 | $0.91 | $0.91 |
Q3 2024 | 7 | $0.98 | $1.00 | $0.99 |
Q4 2024 | 2 | $1.22 | $1.22 | $1.22 |
Q1 2025 | 3 | $1.02 | $1.02 | $1.02 |
Q2 2025 | 3 | $1.23 | $1.23 | $1.23 |
Q3 2025 | 6 | $1.24 | $1.24 | $1.24 |
Q4 2025 | 5 | $1.48 | $1.48 | $1.48 |
Q1 2026 | 4 | $1.19 | $1.19 | $1.19 |
Q2 2026 | 3 | $1.41 | $1.41 | $1.41 |
Q3 2026 | 2 | $1.40 | $1.40 | $1.40 |
Q4 2026 | 2 | $1.71 | $1.71 | $1.71 |
CONMED Corporation Earnings Date And Information
CONMED Corporation last posted its earnings results on Wednesday, July 31st, 2024. The company reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.07. The company had revenue of 330.75 M for the quarter and had revenue of 1.24 B for the year. CONMED Corporation has generated $2 earnings per share over the last year ($2.04 diluted earnings per share) and currently has a price-to-earnings ratio of 20.8. CONMED Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 22nd, 2024 based on prior year's report dates.
CONMED Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/01/2024 | Q2 2024 | $0.97 | $334.39 M | $330.75 M | ||
04/25/2024 | Q1 2024 | $0.64 | $311.63 M | |||
02/28/2024 | Q4 2023 | $1.08 | $327.05 M | |||
10/26/2023 | Q3 2023 | $0.52 | $301.42 M | $304.58 M | ||
07/27/2023 | Q2 2023 | $0.45 | $306.15 M | $317.65 M | ||
04/27/2023 | Q1 2023 | $0.06 | $295.47 M | |||
02/21/2023 | Q4 2022 | $0.87 | $250.87 M | |||
10/27/2022 | Q3 2022 | $1.51 | $280.83 M | $275.09 M | ||
07/28/2022 | Q2 2022 | -$5.65 | $277.19 M | |||
05/05/2022 | Q1 2022 | $0.43 | $242.33 M | |||
02/22/2022 | Q4 2021 | $0.83 | $275.82 M | $273.97 M | ||
10/28/2021 | Q3 2021 | $0.51 | $255.23 M | $248.83 M | ||
07/29/2021 | Q2 2021 | $0.46 | $248.47 M | $255.16 M | ||
04/29/2021 | Q1 2021 | $0.34 | $232.68 M | |||
02/22/2021 | Q4 2020 | $0.84 | $262.90 M | $252.83 M | ||
10/29/2020 | Q3 2020 | $0.24 | $205.92 M | $237.84 M | ||
07/30/2020 | Q2 2020 | -$0.96 | $126.59 M | $157.79 M | ||
04/30/2020 | Q1 2020 | $0.21 | $214.01 M | |||
02/24/2020 | Q4 2019 | $0.53 | $264.83 M | $264.87 M | ||
10/31/2019 | Q3 2019 | $0.25 | $228.20 M | $233.59 M |
CONMED Corporation Earnings: Frequently Asked Questions
-
When is CONMED Corporation's earnings date?
CONMED Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 22nd, 2024 based off last year's report dates.
-
Did CONMED Corporation beat their earnings estimates last quarter?
In the previous quarter, CONMED Corporation (:CNMD) reported $0.98 earnings per share (EPS) to beat the analysts' consensus estimate of $0.91 by $0.07.
-
How can I listen to CONMED Corporation's earnings conference call?
The conference call for CONMED Corporation's latest earnings report can be listened to online.
-
How can I read CONMED Corporation's conference call transcript?
The conference call transcript for CONMED Corporation's latest earnings report can be read online.
-
How much revenue does CONMED Corporation generate each year?
CONMED Corporation (:CNMD) has a recorded annual revenue of $1.24 B.
-
How much profit does CONMED Corporation generate each year?
CONMED Corporation (:CNMD) has a recorded net income of $1.24 B. CONMED Corporation has generated $2.1 earnings per share over the last four quarters.
-
What is CONMED Corporation's price-to-earnings ratio?
CONMED Corporation (:CNMD) has a price-to-earnings ratio of 20.8 and price/earnings-to-growth ratio is 0.12.